Asset manager Steadview has bought $25m of shares in the logistics provider, which counts SoftBank, Fosun and Bennett Coleman & Co as investors.

Novo is set to exit the cancer drug developer in a purchase by another of its shareholders, Boehringer Ingelheim, that could reach $1.43bn.

Intel Capital scored an exit as private equity firm Thoma Bravo bought a majority share of the machine cybersecurity technology producer, valuing it at $1.15bn.

Used vehicle purchase facilitator Reezocar has been bought by Societe Generale two years after the financial services firm supplied it with funding.

The realistic avatar technology developer has been picked by Roblox in a deal allowing Samsung, Gree and Dentsu to exit.

Shares in the antibody discovery platform developer, advancing UBC research, opened at more than three times their IPO price to net it a valuation topping $15bn.

Stanford University has scored an exit after photosensitive polymer-based 3D printing business Origin agreed to a $100m acquisition.

The Eli Lilly-backed antibody discovery platform developer's shares opened at more than three times their IPO price to net it a valuation topping $15bn.

TDK Ventures has scored an exit after 3D printing technology developer Origin after Stratasys agreed to buy it in a deal that could reach $100m.

The company priced an upsized IPO nearly doubling its valuation six months ago. It is part of a the food delivery space which was given a boost by the pandemic.